NPCA Annual Report 2022: Prostate Cancer Care Audit for England and Wales

England and Wales data from the National Prostate Cancer Audit (NPCA) for men diagnosed or treated between April 2020 and March 2021. The dataset reports on care pathway measures, provider participation, patient demographics, and treatment outcomes, including analysis of COVID-19's impact. It is published by the Government Digital Service under a CC-BY-4.0 license.

Use Cases

• Benchmarking NHS provider performance based on reported process and outcome measures.
• Analyzing demographic and treatment variation for low-risk and high-risk localized disease in Wales.
• Studying the impact of COVID-19 on prostate cancer diagnosis and treatment timelines in England and Wales.
• Evaluating two-year post-treatment outcomes for radical prostatectomy and radiotherapy procedures.

Strengths

• Covers all aspects of the prostate cancer care pathway for a defined national cohort.
• Includes specific analysis of COVID -19's impact on diagnosis and treatment in 2020-2021.
• Reports on data completeness and quality from the National Cancer Registration and Analysis Service (NCRAS) and NHS Digital.

Limitations

• Row count and column-level documentation are unknown, limiting suitability assessment.
• Last update date is unknown; freshness unverified.
• Some analyses, like treatment variation for low-risk disease, are limited to Wales only.

Provenance

Source

National Prostate Cancer Audit (NPCA), utilizing data from the National Cancer Registration and Analysis Service (NCRAS), NHS Digital, and the Wales Cancer Network.

Collection Method

Clinical audit based on data submitted by NHS providers in England and Wales.

Time Range

Primary diagnosis/treatment data from 1 April 2020 to 31 March 2021; outcome data for procedures in 2018-2019.

Freshness

Data covers the period from April 2020 to March 2021, with some outcome data from 2018-2019.

Geography

England and Wales.